Australia markets closed

OptimizeRx Corporation (OPRX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
10.62-0.08 (-0.75%)
At close: 04:00PM EDT
10.83 +0.21 (+1.98%)
After hours: 05:29PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
71,522
71,522
62,450
61,293
43,313
Cost of revenue
28,622
28,622
23,483
25,654
19,208
Gross profit
42,900
42,900
38,967
35,638
24,105
Operating expenses
Research development
-
-
-
-
1,081
Selling general and administrative
58,020
58,020
49,236
33,191
23,354
Total operating expenses
60,422
60,422
51,258
35,277
26,241
Operating income or loss
-17,522
-17,522
-12,291
361.1
-2,135
Interest expense
1,454
1,454
0
-
-
Total other income/expenses net
-8,380
-8,380
-
-
-140.39
Income before tax
-25,164
-25,164
-11,438
378.079
-2,207
Income tax expense
-7,598
-7,598
0
0
0
Income from continuing operations
-17,566
-17,566
-11,438
378.079
-2,207
Net income
-17,566
-17,566
-11,438
378.079
-2,207
Net income available to common shareholders
-17,566
-17,566
-11,438
378.079
-2,207
Basic EPS
-0.81
-
-0.64
0.02
-0.15
Diluted EPS
-0.81
-
-0.64
0.02
-0.15
Basic average shares
16,969
-
17,784
17,228
14,828
Diluted average shares
16,969
-
17,784
17,690
14,828